Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
46.27%Return on Equity
VS
Market
Sector
Industry
History
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 104.72M | $ 48.45M | 46.27% |
| 3/31/2025 | $ 97.11M | $ 38.07M | 39.2% |
| 12/31/2024 | $ 92.13M | $ 30.28M | 32.87% |
| 9/30/2024 | $ 71.09M | $ 23.24M | 32.69% |
| 6/30/2024 | $ 48.51M | $ 8.72M | 17.98% |
| 3/31/2024 | $ 50.98M | $ 15.38M | 30.16% |
| 12/31/2023 | $ 53.44M | $ 21.59M | 40.4% |
| 9/30/2023 | $ 38.74M | $ 3.72M | 9.59% |
| 6/30/2023 | $ 30.4M | $ -2.44M | -8.02% |
| 3/31/2023 | $ 25.85M | $ 4.81M | 18.59% |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average ROE has been -52.26%.
- The median ROE for PUMA BIOTECHNOLOGY INC during this period was 18.29%
- PUMA BIOTECHNOLOGY INC reached its highest ROE over the past 5 years at 46.27%.
- The lowest ROE recorded by PUMA BIOTECHNOLOGY INC in the same timeframe -685.19%
PUMA BIOTECHNOLOGY INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for PUMA BIOTECHNOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -56.2M ] / Equity [ $ -453K ]
(=) ROE [ 0% ] PBYI - Return on Equity, Last 5 years
-685.19%
Minimum
Mar 31, 2022
46.27%
Maximum
Jun 30, 2025
-52.26%
Average
18.29%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |